- Report
- January 2022
- 60 Pages
Global
From €3485EUR$3,950USD£3,016GBP
- Report
- March 2025
- 180 Pages
Global
From €3970EUR$4,500USD£3,436GBP
- Report
- August 2024
- 80 Pages
Japan
From €3088EUR$3,500USD£2,672GBP
- Report
- June 2024
- 180 Pages
Global
From €3970EUR$4,500USD£3,436GBP
- Report
- November 2023
- 185 Pages
Global
From €3970EUR$4,500USD£3,436GBP
- Report
- October 2023
- 82 Pages
United States
From €3088EUR$3,500USD£2,672GBP
- Report
- April 2023
- 84 Pages
Europe
From €3529EUR$4,000USD£3,054GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1103EUR$1,250USD£954GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1765EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1765EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1765EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1103EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1103EUR$1,250USD£954GBP
- Report
- October 2024
- 318 Pages
Global
From €7014EUR$7,950USD£6,069GBP
- Report
- September 2024
- 132 Pages
Global
From €7014EUR$7,950USD£6,069GBP
- Report
- March 2024
- 397 Pages
Global
From €7014EUR$7,950USD£6,069GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2426EUR$2,750USD£2,099GBP
- Drug Pipelines
- July 2023
- 30 Pages
Global
From €2426EUR$2,750USD£2,099GBP

The Antipsychotic Drug market is a segment of the Central Nervous System Drugs market. Antipsychotic drugs are used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. These drugs work by blocking dopamine receptors in the brain, which helps to reduce the symptoms of psychosis. Common side effects of antipsychotic drugs include drowsiness, weight gain, and dry mouth.
The Antipsychotic Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Eli Lilly, Pfizer, Johnson & Johnson, Novartis, and AstraZeneca. These companies have a wide range of products, including both branded and generic drugs. Additionally, many of these companies have developed new formulations of existing drugs, such as long-acting injectables, to improve patient compliance. Show Less Read more